
For this iteration of the SVM journal club, we welcome our friends from Stanford, Drs. Eri Fukaya, Blake Iceton, and Leeper, to review the role of Lipoprotein(a) in PAD and discuss the recent publication in NEJM evaluating the use of Lepodisiran, an extended-duration, small interfering RNA targeting Lipoprotein(a).
We look forward to seeing you then. As always, please feel free to share the invite with friends and colleagues.
For this iteration of the SVM journal club, we welcome Dr. Nichole Brunton to review the recent PEERLESS publication in Circulation evaluating the outcomes of large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary emboli (article attached).
We look forward to seeing you then. As always, please feel free to share the invite with friends and colleagues.